DrugCard

Description / Opis

founders
Popular

DrugCard

Transforming drug safety with scientific literature and AI Insights

DrugCard, a groundbreaking tool enhances the safety of medicines by using advanced technology to gather critical safety information. Our tool scans over 1000 medical journals in 100 different languages, looking for mentions of drug safety issues like side effects or adverse reactions, and collects this data quickly and accurately.

The core of our innovation is a blend of OCR, parsers, crawlers and AI. These technologies allow us to read and analyze both online and printed medical journals, ensuring we find all mentions of drugs and safety information. This comprehensive approach helps identify potential safety issues that others might miss, contributing to better patient safety.

One of the standout features of our system is its efficiency. Traditional methods of reviewing medical journals are slow and require a lot of manual effort, often taking weeks or months. Our tool performs this task much faster, making the process eight times more efficient. This speed enables pharmaceutical companies to obtain crucial safety information quickly, helping them respond to issues more effectively.

We also provide a high degree of customization for our clients. If a pharmaceutical company needs to monitor specific journals or countries, we can add these to our system within two weeks, significantly faster than the industry standard of six months. This flexibility ensures our clients always have access to the latest and most relevant information.

BASIC INFORMATION

Company name / Nazwa firmy
DrugCards OÜ
Company info / Opis firmy [1 000 words]
DrugCard provides full-regulatory compliant SaaS to help pharmacovigilance teams, trimming literature screening time by 70% and generating deeper insights about drug safety using sophisticated parsers and AI-tech

DrugCard has quickly become a key player in one of the most conservative industries in the world: pharmaceuticals. Within just two years, we have expanded to 14 EU countries, including Poland, partnering with major companies like Adamed, Polpharma, and Biofarm. Our innovative SaaS solution revolutionizes pharmacovigilance by automating literature screening, which drastically reduces the time and effort required for compliance.

We manage the largest database of local journals in various languages, offering unmatched coverage and accuracy. Our proprietary technology, combining OCR, parsers, and crawlers, processes both online and hard copy journals, identifying more drug mentions than any competitor. We also offer the unique capability to add custom journals and countries in just two weeks, compared to the six months it takes others.

Our solution not only meets but exceeds EU regulatory requirements, ensuring precise and reliable drug safety information. By leveraging cutting-edge technology, DrugCard transforms drug safety, providing deeper insights and greater efficiency. Our services cover drug safety data collection from 50 countries, supporting our clients in maintaining stringent regulatory compliance and enhancing patient safety.
Country / Kraj
Estonia / Estonia
Founding year / Rok założenia
2021
Team size / Wielkość zespołu
20
Company size / Wielkość firmy
Small company / Mała firma
Legal form / Forma prawna
Limited Liability Company LLC / Spółka Z O.O.
Company www / Strona firmowa
LinkedIn profil / LinkedIn profil
Sector / Branża
Zdrowie / Health
Email / Email
Address
Ruunaoja tn 3
Zip/Post Code
11415

Contest Information

Contest Category / Kategoria Konkursu
ZDROWIE / MED-TECH / WELLBEING
Kind of innovation / Rodzaj innowacji
Product / Produktowa, Technological / Technologiczna, Science / Naukowa
Target market / Rynek docelowy
Global Market / Rynek światowy
Customer focus / Kluczowy odbiorcy
B2B
Reach of innovation / Zasięg innowacji
European / Europejski, Global / Światowy
Justification for Jury / Uzasadnienie [500 words]
DrugCard’s tool deserves an award because we are the only company that can quickly and accurately combine and analyze unstructured texts from medical journals in 50 countries in their local languages. This is particularly challenging, even for AI, because the causality and correlations in scientific texts are often unclear. Our system efficiently gathers vital information about possible adverse events, overdoses, drug interactions, use during pregnancy, and use in children. We provide this data to pharmaceutical companies so they can take appropriate actions to prevent these effects from happening to patients. This not only improves the safety of drugs globally but also positively impacts company reputations and patient health. Our comprehensive and efficient approach sets a new standard in drug safety monitoring, ensuring that medicines are safer for everyone.
What makes your company stand out from the competition? / Czym wyróżnia się Twoja firma na tle konkurencji?
Revolutionizes existing industry standards / Rewolucjonizuje dotychczasowe zasady w branży
Key technologies / Kluczowe technologie
OCR, parsers, crawlers, Kubernetes, AWS, AI for data analysis, multi-language support.
Financial standing / Sytuacja finansowa
499 000 - 999 000 EURO
What sources of financing do you use when running your company? / Z jakich Źródeł finansowania korzystasz podczas prowadzenia firmy?
Accelerator / Akcelerator, Private Investors / Prywatni inwestorzy, Angel Investors, Venture Capital

Start-up logo, presentation video / Start-up logo, prezentacja, wideo

Company logo / Logo firmy [600x600 px]
Additional information / Dodatkowe informacje [PDF - 64 MB Max]
Who submit the application / Kto dokonuje zgłoszenia
Company / Firma
How did you find out about the contest? / Jak dowiedziałeś się o konkursie?
Facebook

Entry by / Zgłoszenie przez:

dhorilyk

Member since 1 month ago
View Profile
Scroll To Top
  • Menu
Close

Your Cart 0

Close

No products in the cart.

Return To Shop
Sidebar